Stay updated on Venetoclax in Relapsed AML Children Clinical Trial
Sign up to get notified when there's something new on the Venetoclax in Relapsed AML Children Clinical Trial page.

Latest updates to the Venetoclax in Relapsed AML Children Clinical Trial page
- Check6 days agoChange DetectedA new version entry (v3.3.4) updates the Study Status and Contacts/Locations; the history shows 2026-01-12 (revision 29) and 2026-01-13 (Revision: v3.3.4), with the prior 2025-12-15 Revision: v3.3.3 listed as deleted.SummaryDifference0.4%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded a new revision entry 'Revision: v3.3.3' to the page history, and removed 'HHS Vulnerability Disclosure' and the older 'Revision: v3.3.2' entry.SummaryDifference0.1%

- Check35 days agoChange DetectedAdded/updated Contacts/Locations and Study Status sections, reflecting updated contact details and the current status of the trial.SummaryDifference0.4%

- Check50 days agoChange DetectedAdded Contacts/Locations and Study Status sections with a new revision (v3.3.2) on 2025-11-24; the previous revision (v3.3.1) was removed.SummaryDifference0.5%

- Check57 days agoChange DetectedRevision: v3.3.1 added and v3.2.0 removed, reflecting an update to the record history; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedThe funding/operating status banner was removed from the page. The study record history is displayed without the previous alert.SummaryDifference0.5%

Stay in the know with updates to Venetoclax in Relapsed AML Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax in Relapsed AML Children Clinical Trial page.